Lynette M. Sholl

2007–2025 年に発表

233
論文数
36,599
被引用数
97
h 指数
220
i10 指数

被引用数

Lynette M. Sholl の年別被引用数1971 年: 被引用 1 件1976 年: 被引用 1 件1993 年: 被引用 2 件2000 年: 被引用 6 件2001 年: 被引用 1 件2002 年: 被引用 2 件2003 年: 被引用 1 件2004 年: 被引用 1 件2007 年: 被引用 1 件2008 年: 被引用 3 件2009 年: 被引用 3 件2010 年: 被引用 20 件2011 年: 被引用 35 件2012 年: 被引用 28 件2013 年: 被引用 58 件2014 年: 被引用 78 件2015 年: 被引用 152 件2016 年: 被引用 282 件2017 年: 被引用 299 件2018 年: 被引用 395 件2019 年: 被引用 1,275 件2020 年: 被引用 1,770 件2021 年: 被引用 2,096 件2022 年: 被引用 1,906 件2023 年: 被引用 1,641 件2024 年: 被引用 2,571 件2025 年: 被引用 1,528 件2026 年: 被引用 104 件1972〜1975 年は被引用が無いため表示していません1977〜1992 年は被引用が無いため表示していません1994〜1999 年は被引用が無いため表示していません2005〜2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,856 件、この内訳の 25.7%中国: 引用元論文 3,066 件、この内訳の 16.2%イタリア: 引用元論文 1,117 件、この内訳の 5.9%イギリス: 引用元論文 952 件、この内訳の 5%ドイツ: 引用元論文 753 件、この内訳の 4%日本: 引用元論文 747 件、この内訳の 4%フランス: 引用元論文 694 件、この内訳の 3.7%カナダ: 引用元論文 622 件、この内訳の 3.3%スペイン: 引用元論文 612 件、この内訳の 3.2%オランダ: 引用元論文 433 件、この内訳の 2.3%韓国: 引用元論文 426 件、この内訳の 2.3%スイス: 引用元論文 417 件、この内訳の 2.2%
0%25.7%その他 22.2%

分野

  • Medicine69%
  • Biochemistry, Genetics and Molecular Biology22.3%
  • Immunology and Microbiology4.2%
  • Computer Science2%
  • Engineering1%
  • Neuroscience0.3%
  • その他1.2%

トピック

  • Cancer Immunotherapy and Biomarkers9.6%
  • Lung Cancer Treatments and Mutations9.1%
  • Cancer Genomics and Diagnostics5.3%
  • Lung Cancer Research Studies4.1%
  • Lung Cancer Diagnosis and Treatment3.5%
  • Immunotherapy and Immune Responses2.1%
  • その他66.3%

共著者

全論文

検索で開く
  1. PD-L1 as a biomarker of response to immune-checkpoint inhibitors

    著者: , , , , , , , , , - Nature Reviews Clinical Oncology 2021 被引用: 1,560

  2. Acquired Resistance to KRAS G12C Inhibition in Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J. David Lawson, Peter Olson, Piro Lito, Sai-Hong I. Ou, James G. Christensen, Pasi A. Jänne, Andrew J. Aguirre - New England Journal of Medicine 2021 被引用: 1,164

  3. A pathology foundation model for cancer diagnosis and prognosis prediction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2024 被引用: 430

  4. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

    著者: , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2021 被引用: 1,481

  5. STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brett W. Carter, Jeremy Erasmus, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Mizuki Nishino, Warren L. Denning, Ana Galán‐Cobo, Haïfa Hamdi, Taghreed Hirz, Pan Tong, Jing Wang, Jaime Rodriguez‐Canales, Pamela Villalobos, Edwin R. Parra, Neda Kalhor, Lynette M. Sholl, Jennifer L. Sauter, Achim A. Jungbluth, Mari Mino–Kenudson, Roxana Azimi, Yasir Y. Elamin, Jianjun Zhang, Giulia C. Leonardi, Fei Jiang, Kwok‐Kin Wong, J. Jack Lee, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, Vincent A. Miller, Garrett M. Frampton, Jedd D. Wolchok, Alice T. Shaw, Pasi A. Jänne, Philip J. Stephens, Charles M. Rudin, William J. Geese, Lee A. Albacker, John V. Heymach - Cancer Discovery 2018 被引用: 1,604

  6. Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2021 被引用: 645

  7. Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Justin F. Gainor, Matthew D. Hellmann, Mark M. Awad - Journal of Thoracic Oncology 2021 被引用: 367

  8. Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eliezer M. Van Allen, Mizuki Nishino, Lynette M. Sholl, David C. Christiani, Xihong Lin, Scott J. Rodig, Matthew D. Hellmann, Mark M. Awad - JAMA Oncology 2022 被引用: 384

  9. Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer

    著者: , , , , , , , , , , , , , , , , - Cancer Discovery 2018 被引用: 515

  10. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masayuki Noguchi, Claudia Poleri, Natasha Rekhtman, Ming‐Sound Tsao, Erik Thunnissen, William D. Travis, Yasushi Yatabe, Anja C. Roden, Jillian B. Daigneault, Ignacio I. Wistuba, Keith M. Kerr, Harvey I. Pass, Andrew G. Nicholson, Mari Mino–Kenudson - Journal of Thoracic Oncology 2020 被引用: 541

  11. Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Filer, Fiona Powrie, Christopher D. Buckley, Michael B. Brenner, Soumya Raychaudhuri - Med 2022 被引用: 224

  12. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer

    著者: , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2017 被引用: 522

  13. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ugo Pastorino, Luis Paz‐Ares, Giuseppe Pelosi, Claudia Poleri, Mariano Provencio, Anja C. Roden, Giorgio V. Scagliotti, Stephen G. Swisher, Erik Thunnissen, Ming‐Sound Tsao, Johan Vansteenkiste, Walter Weder, Yasushi Yatabe - Journal of Thoracic Oncology 2020 被引用: 450

  14. Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xitao Wang, Bowen Chen, Fangxin Hong, Lynette M. Sholl, Michael Tolstorukov, Kathleen L. Pfaff, Pasi A. Jänne, Evisa Gjini, Robin Edwards, Scott J. Rodig, Ellis L. Reinherz, Matthew G. Oser, David A. Barbie - Cancer Discovery 2021 被引用: 214

  15. Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 被引用: 1,242

  16. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    著者: , , , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2018 被引用: 931

  17. Assessment of Resistance Mechanisms and Clinical Implications in Patients WithEGFRT790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

    著者: , , , , , , , , , , , , , , - JAMA Oncology 2018 被引用: 689

  18. MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

    著者: , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 688

  19. Association of clonal hematopoiesis with chronic obstructive pulmonary disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jerome I. Rotter, Ramachandran S. Vasan, Bing Yu, Lynette M. Sholl, Donna Neuberg, Siddhartha Jaiswal, Bruce D. Levy, Caroline A. Owen, Pradeep Natarajan, Edwin K. Silverman, Peter van Galen, Yohannes Tesfaigzi, Michael H. Cho, Benjamin L. Ebert - Blood 2021 被引用: 229

  20. Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2019 被引用: 336

  21. Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

    著者: , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2022 被引用: 215

  22. Association of Machine Learning–Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC

    著者: , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2022 被引用: 131

  23. Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary

    著者: , , , , , , , , - Nature Medicine 2023 被引用: 112

  24. Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eliezer M. Van Allen - Nature Genetics 2018 被引用: 696